JI
Sen. James Inhofe (R-OK) sold $50K-$100K of CRSP stock
James Inhofe, U.S. Senator (R-OK), disclosed a sale of CRISPR Therapeutics AG (CRSP) stock worth $50K-$100K in a STOCK Act filing on Dec 23, 2020.
The trade happened on Dec 22, 2020, 1 day before it was made public.
CRSP has moved -74.9% since the trade date, from $170.08 to $42.62 (Nov 12, 2026 close).
- Traded
- Dec 22, 2020
- Disclosed
- Dec 23, 2020
- Filing delay
- 1 day
- Price since
- -74.9%
- Source
- STOCK Act disclosure